- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/26 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
Patent holdings for IPC class C07D 209/26
Total number of patents in this class: 109
10-year publication summary
|
10
|
4
|
6
|
7
|
6
|
3
|
10
|
9
|
7
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vanderbilt University | 1987 |
8 |
| Janssen Pharmaceuticals, Inc. | 440 |
6 |
| Katholieke Universiteit Leuven | 1260 |
6 |
| The Trustees of the University of Pennsylvania | 4400 |
5 |
| Novartis AG | 10340 |
4 |
| Allergan, Inc. | 2204 |
3 |
| Merck Sharp & Dohme LLC | 3736 |
3 |
| Beijing Anjianxi Bio-Medical Technology Co., Ltd. | 3 |
3 |
| F. Hoffmann-La Roche AG | 7847 |
2 |
| Hoffmann-La Roche Inc. | 3722 |
2 |
| Emory University | 1705 |
2 |
| Korea Research Institute of Bioscience and Biotechnology | 1062 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 425 |
2 |
| The Rockefeller University | 580 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3273 |
2 |
| Armagen, Inc. | 33 |
2 |
| Beijing An Jian Xi Bio-Medical Technology Co., Ltd. | 2 |
2 |
| Diaccurate | 28 |
2 |
| Risen (Suzhou) Pharma Tech Co., Ltd. | 74 |
2 |
| Shanghai Junshi Biosciences Co., Ltd. | 115 |
2 |
| Other owners | 47 |